Manufacturing and Production

Showing 15 posts of 5863 posts found.

ai_graphic

The future is now: The transformative power of AI

February 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …
nektar-therapeutics

Rapidly-growing Nektar Therapeutics reportedly considering sale of its business

February 5, 2018 Manufacturing and Production, Sales and Marketing M&A, MA, Nektar, Nektar Therapeutics, acquisition, pharma

After a slew of M&A deals throughout the first month of 2018, including Celgene’s buyout of Juno Therapeutics for $9 …
india-coor-locator

64% of FDC antibiotics in India are unapproved, report reveals

February 5, 2018 Manufacturing and Production, Sales and Marketing Antibiotics, India, antimicrobial resistance, pharma

The majority of fixed dose combination (FDC) antibiotics that are made and sold in India are still unapproved, despite promises …
20170105_studio_profielfoto___marco_avila_05_web

Working Life: Marco Avila, Vice President of Medical Affairs, Teva Europe

February 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, Working Life

Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, …
online

Ipsen promotes new CMO from within

January 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen has announced that Sotirios G. Stergiopoulos will become its newest Chief Medical Officer, performing the role alongside his current …
dengvaxia

Philippines’ Department of Health demands full refund of $70m Dengvaxia programme from Sanofi

January 30, 2018 Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …

Apotex President resigns amidst Founder’s murder and allegations of accepting Teva secrets

January 30, 2018 Manufacturing and Production, Medical Communications Apotex, Jeremy Desai, Teva, pharma

Following the alleged murder of its founder Barry Sherman and his wife in December last year, Canada’s largest generic drug …
bob_hugin1

Celgene Executive Chairman Bob Hugin to retire

January 30, 2018 Manufacturing and Production, Medical Communications Bob Hugin, Celgene, pharma

Fresh from its acquisition of Juno Therapeutics, Celgene has announced that its Executive Chairman Bob Hurgin is to retire effective …
squirrel-monkey-1335598_960_720

FDA revises methods, after public outrage at testing of monkeys

January 29, 2018 Manufacturing and Production, Medical Communications FDA, biotech, drugs, pharma, pharmaceutical

The story broke in September of last year that the FDA was testing nicotine addiction in squirrel monkeys and that …
cambridge_biomedical_campus

Delivering the life sciences agenda: Easy as ABC

January 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical

Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …
alex_azar_wwsg_photo_cropped

Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate

January 25, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …
jj_sign_on_wall

J&J withdraws controversial vaginal mesh from Australian market

January 23, 2018 Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, pharma, vaginal mesh

Johnson & Johnson has withdrawn its controversial vaginal mesh product from the Australian market after missing a deadline requiring all …
The Gateway to Local Adoption Series

Latest content